Olivier Laureau, President of the Servier Group, discusses how Servier´s economic model is based on considerable investments in R&D to provide for a better future and on a strong international footprint; and how their ambition is to grow from total revenues of 4 billion euros (4.46 billion USD) today, to 5 billion euros (5.57 billion USD) over the next five years. Mr Laureau also reveals how Servier’s particular set-up, as a foundation, allows them to have a long term view when it comes to achieving such an objective.
The pharmaceutical sector in France has gone through some challenging times in recent years. What can be done to restore the image of this industry?
"A commitment to therapeutic progress for the benefit of the patient is our key concern."
